Creo Medical Group (LON:CREO) Sets New 1-Year Low – What’s Next?

Creo Medical Group PLC (LON:CREO) shares reached a new 52-week low on Monday . The company traded as low as GBX 19.86 ($0.26) and last traded at GBX 20.02 ($0.26), with a volume of 4276025 shares changing hands. The stock had previously closed at GBX 20.45 ($0.27).

Creo Medical Group Price Performance

The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96. The business’s 50-day moving average is GBX 26.82 and its two-hundred day moving average is GBX 31.54. The company has a market capitalization of £72.42 million, a P/E ratio of -333.65 and a beta of 0.86.

Insider Transactions at Creo Medical Group

In other Creo Medical Group news, insider Kevin Crofton acquired 2,916,666 shares of Creo Medical Group stock in a transaction on Monday, October 21st. The stock was purchased at an average price of GBX 24 ($0.31) per share, for a total transaction of £699,999.84 ($914,076.57). Company insiders own 22.43% of the company’s stock.

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.